US8609858: Spiro derivatives of parthenin as novel anticancer agents
The invention relates to novel spiro derivatives of parthenin prepared by the dipolar cycloaddition of various dipoles viz, benzonitrile oxides, nitrones, azides, nitrile ylide diazoalkane, nitrile imide, ozone, azomethine imides, azomethine ylides etc. with exocyclic double bond of C ring (?-methylene-?-butyrolactone). Representative compounds have been screened for their anticancer activity against different cancer cell lines. ICs0 value of these analogues varies between 4.3 µM to 93 µM. A mechanistic correlation of their anticancer activity has been described. The results of the cytotoxicity test of the compounds studies indicated that the ?, ?-unsaturated ketonic moiety in parthenin plays an important role in the maintenance of the high level of cytotoxicity.
Patent No:
US8609858
Application No:
12/921061
Filing Date:
29-04-2011
Issue Date:
17-12-2013
Applicant:
CSIR-Indian Institute of Integrative Medicine (CSIR-IIIM), Jammu
Disclaimer:
Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.
Please enter your details
Please provide your name and email to continue. Your details are saved in this browser for future use.
Latest Updates
Loading…
⚠️
You are leaving this website
You are about to be redirected to an external website that is not operated by
India Science, Technology & Innovation (ISTI) Portal.